Report
Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
Meghan M. Verstraetea Zymeworks Inc, Vancouver, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-0422-2826View further author information
https://orcid.org/0000-0003-0422-2826View further author information, Florian Heinkela Zymeworks Inc, Vancouver, Canadahttps://orcid.org/0000-0002-2383-9330View further author information
https://orcid.org/0000-0002-2383-9330View further author information, , , Anh Tranb Department of Human Health Therapeutics, National Research Council Canada, Ottawa, Canadahttps://orcid.org/0000-0003-0644-6014View further author information
https://orcid.org/0000-0003-0644-6014View further author information, , , , , , Jegarubee Bavananthasivamb Department of Human Health Therapeutics, National Research Council Canada, Ottawa, Canadahttps://orcid.org/0000-0002-0332-4823View further author information
https://orcid.org/0000-0002-0332-4823View further author information, , , , , , , , & Eric Escobar-Cabreraa Zymeworks Inc, Vancouver, Canadahttps://orcid.org/0000-0002-2749-8860View further author information
https://orcid.org/0000-0002-2749-8860View further author information show all